Skip to main content
. 2013 Sep 14;36(10):2923–2930. doi: 10.2337/dc12-2012

Figure 1.

Figure 1

Effect of GFT505 on human skeletal muscle gene expression. Gene (mRNA) expression in skeletal muscle biopsy specimens at the end of the first 8-week treatment period with GFT505 (80 mg/day) or placebo (n = 9/group). mRNA levels were measured by quantitative PCR. Values (means ± SD) are normalized to the expression of 18S and are expressed relative to placebo group. PCB, placebo group.